Renata Ferrarotto

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

First use of AXL-targeting in adenoid cystic carcinoma (ACC); with positive results, ACC now included in AXL studies.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

Steven Frank

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Marie-Claude Hofmann

Professor

The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

UNITED STATES
View details

Ehab Y. Hanna

-

UNITED STATES
View details

Jack Phan

Physician/Associate Professor

MD Anderson Cancer Center

UNITED STATES
View details

Michelle Afkhami, MD

Chief, Division of Molecular Pathology & Therapy Biomarkers; CLIA Lab Director, COH-Clinical Molecular Genomics and Cytogenomics Laboratory; Medical Director, Cytogenetics Laboratory and Clinical Molecular Diagnostic Laboratory; Director, Core Cytogenetics Laboratory, Beckman Research Institute

City of Hope

UNITED STATES
View details

Cielito Reyes-Gibby

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Yoshitsugu Mitani

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Kevin Contrera

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Anastasios Maniakas

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.